The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-[5-[[3-(4-ethoxy-3-methyl-phenyl)-1-phenyl-pyrazol-4-yl]methylene]-4-oxo-2-thioxo-thiazolidin-3-yl]propanoic acid ID: ALA4584003
PubChem CID: 1315240
Max Phase: Preclinical
Molecular Formula: C25H23N3O4S2
Molecular Weight: 493.61
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCOc1ccc(-c2nn(-c3ccccc3)cc2/C=C2\SC(=S)N(CCC(=O)O)C2=O)cc1C
Standard InChI: InChI=1S/C25H23N3O4S2/c1-3-32-20-10-9-17(13-16(20)2)23-18(15-28(26-23)19-7-5-4-6-8-19)14-21-24(31)27(25(33)34-21)12-11-22(29)30/h4-10,13-15H,3,11-12H2,1-2H3,(H,29,30)/b21-14-
Standard InChI Key: PUYYKYHFODSMQI-STZFKDTASA-N
Molfile:
RDKit 2D
34 37 0 0 0 0 0 0 0 0999 V2000
33.2617 -6.0583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4309 -6.0583 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.1790 -5.2455 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.8352 -4.7724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5115 -5.2682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2949 -5.0562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8704 -5.6317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6728 -5.4165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1278 -6.1367 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.6149 -6.7661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8362 -6.4590 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
35.8228 -7.5495 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
36.9428 -6.1367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3462 -5.4330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1570 -5.4330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5645 -4.7294 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.5645 -6.1367 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.8848 -4.6331 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.8352 -3.9574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1316 -3.5537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1327 -2.7423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8366 -2.3346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5405 -2.7373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5431 -3.5516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8366 -1.5238 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.1330 -1.1163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4294 -1.5238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4291 -2.3348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0234 -6.7619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4306 -7.4658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0239 -8.1659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2086 -8.1659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8021 -7.4684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2075 -6.7619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
5 4 1 0
1 5 2 0
5 6 1 0
6 7 2 0
8 7 1 0
8 9 1 0
9 10 1 0
11 10 1 0
7 11 1 0
10 12 2 0
9 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
15 17 2 0
8 18 2 0
19 4 1 0
20 19 2 0
21 20 1 0
22 21 2 0
23 22 1 0
24 23 2 0
19 24 1 0
22 25 1 0
25 26 1 0
26 27 1 0
21 28 1 0
29 2 1 0
30 29 2 0
31 30 1 0
32 31 2 0
33 32 1 0
34 33 2 0
29 34 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 493.61Molecular Weight (Monoisotopic): 493.1130AlogP: 4.92#Rotatable Bonds: 8Polar Surface Area: 84.66Molecular Species: ACIDHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.01CX Basic pKa: 1.34CX LogP: 5.51CX LogD: 2.36Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.35Np Likeness Score: -2.00
References 1. (2017) Arf6 inhibitors and methods of synthesis and use thereof,